StockWatch: Amid Nvidia Turmoil, What Happens to Its Life Sciences Collaborations?
While Nvidia doesn’t develop new therapies, instruments, or reagents, its AI technology powers numerous collaborations with biopharma and lab tools giants stretching back at least five years.